17,37 €
Mehr erfahren.
- Herausgeber: Bentham Science Publishers
- Kategorie: Ratgeber
- Serie: Medicine Demystified
- Sprache: Englisch
- Veröffentlichungsjahr: 2020
The Regeneration Promise is a reader friendly guide to the world of regenerative medicine and stem cell technology. It covers the history of stem cell technology as a general introduction to the subject and then continues with a description of the many known types of stem cell and how these can potentially be used to treat disease. The author explains the pros and cons of using stem cell technology to treat patients in simple and factual terms throughout the book, while clarifying many stem cell myths. There is valuable advice for people considering undergoing stem cell therapy and also for those who are considering stem cell storage such as umbilical cord blood storage at the birth of a baby. The book also covers information on current research in stem cell technology and how this may be useful in the clinic, as promising regenerative medicine treatments emerge in the near future. The simple use of language with clear explanation of scientific terms, where applicable, make this book an accessible source of information for anyone interested in enhancing their general knowledge about regenerative medicine when considering such treatment options and understanding the debate surrounding stem cell technology and its use in disease therapy.
Das E-Book können Sie in Legimi-Apps oder einer beliebigen App lesen, die das folgende Format unterstützen:
Seitenzahl: 219
Ähnliche
BENTHAM SCIENCE PUBLISHERS LTD.
End User License Agreement (for non-institutional, personal use)
This is an agreement between you and Bentham Science Publishers Ltd. Please read this License Agreement carefully before using the ebook/echapter/ejournal (“Work”). Your use of the Work constitutes your agreement to the terms and conditions set forth in this License Agreement. If you do not agree to these terms and conditions then you should not use the Work.
Bentham Science Publishers agrees to grant you a non-exclusive, non-transferable limited license to use the Work subject to and in accordance with the following terms and conditions. This License Agreement is for non-library, personal use only. For a library / institutional / multi user license in respect of the Work, please contact: [email protected].
Usage Rules:
All rights reserved: The Work is the subject of copyright and Bentham Science Publishers either owns the Work (and the copyright in it) or is licensed to distribute the Work. You shall not copy, reproduce, modify, remove, delete, augment, add to, publish, transmit, sell, resell, create derivative works from, or in any way exploit the Work or make the Work available for others to do any of the same, in any form or by any means, in whole or in part, in each case without the prior written permission of Bentham Science Publishers, unless stated otherwise in this License Agreement.You may download a copy of the Work on one occasion to one personal computer (including tablet, laptop, desktop, or other such devices). You may make one back-up copy of the Work to avoid losing it.The unauthorised use or distribution of copyrighted or other proprietary content is illegal and could subject you to liability for substantial money damages. You will be liable for any damage resulting from your misuse of the Work or any violation of this License Agreement, including any infringement by you of copyrights or proprietary rights.Disclaimer:
Bentham Science Publishers does not guarantee that the information in the Work is error-free, or warrant that it will meet your requirements or that access to the Work will be uninterrupted or error-free. The Work is provided "as is" without warranty of any kind, either express or implied or statutory, including, without limitation, implied warranties of merchantability and fitness for a particular purpose. The entire risk as to the results and performance of the Work is assumed by you. No responsibility is assumed by Bentham Science Publishers, its staff, editors and/or authors for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products instruction, advertisements or ideas contained in the Work.
Limitation of Liability:
In no event will Bentham Science Publishers, its staff, editors and/or authors, be liable for any damages, including, without limitation, special, incidental and/or consequential damages and/or damages for lost data and/or profits arising out of (whether directly or indirectly) the use or inability to use the Work. The entire liability of Bentham Science Publishers shall be limited to the amount actually paid by you for the Work.
General:
Any dispute or claim arising out of or in connection with this License Agreement or the Work (including non-contractual disputes or claims) will be governed by and construed in accordance with the laws of Singapore. Each party agrees that the courts of the state of Singapore shall have exclusive jurisdiction to settle any dispute or claim arising out of or in connection with this License Agreement or the Work (including non-contractual disputes or claims).Your rights under this License Agreement will automatically terminate without notice and without the need for a court order if at any point you breach any terms of this License Agreement. In no event will any delay or failure by Bentham Science Publishers in enforcing your compliance with this License Agreement constitute a waiver of any of its rights.You acknowledge that you have read this License Agreement, and agree to be bound by its terms and conditions. To the extent that any other terms and conditions presented on any website of Bentham Science Publishers conflict with, or are inconsistent with, the terms and conditions set out in this License Agreement, you acknowledge that the terms and conditions set out in this License Agreement shall prevail.Bentham Science Publishers Pte. Ltd. 80 Robinson Road #02-00 Singapore 068898 Singapore Email: [email protected]
PREFACE
The aim of this book is to bring a clear understanding and appreciation of stem cell technology and the related subject of regenerative medicine to everyone and especially to those people considering paying for stem cell therapy or stem cell related services. It avoids complex scientific terminology (or it is clearly and simply defined where needed) and develops ideas in a coherent and understandable fashion for the general reader.
The subject of stem cell technology and the related possible regenerative medicine procedures is an area of science and medicine where there is much confusion, often supported by unproven claims. There are currently many clinics offering stem cell ‘treatments’ which are driven by profit with no concern for the safety or well-being of the patient. There are untested and unproven stem cell based ‘treatments’ being offered to vulnerable patients around the globe and these are often sold at a very high price. If these ‘treatments’ were offered free of charge, it would still be scandalous behaviour by those offering such treatments because the ‘treatments’ are untested and unproven and could even pose a health risk to vulnerable, often terminally or acutely ill recipient patients.
The general public, who are the people most likely to consider, or to be offered stem cell-based therapies, in most instances often have little or no understanding of stem cell technology and put their trust in ‘clinic’ salesmen.
This is not the fault of the patients, it is the fault of those people who wish to draw such patients into a web of deceit.
The salesmen who represent the clinics often have no knowledge or formal training in stem cell technology at all and are all driven by profit. The result of this is that vulnerable patients, who may be suffering from life threatening or life changing diseases, are drawn into costly stem cell procedures which are at best unproven and could sometimes even be damaging rather than beneficial to their health. This must stop. This book will give everyone the knowledge to assess and reject such ‘treatments’ if they are inappropriate. Patients must be prepared to walk away if they have any doubts about the safety and efficacy of any proposed treatment and if a treatment does commence, it must always be under informed consent.
It is not just the general public and potential patients who need stem cell information. Many practising physicians have had little or no stem cell training in medical school, most journalists have no knowledge at all in the subject and politicians make life changing decisions on the use and availability of stem cell technology often based on a very poor level of understanding. The book will also be a useful resource to students both in school and University who want to begin their understanding of stem cell technology and become the stem cell pioneers of the future. Thorough training of our future physicians, scientists and businessmen in stem cell concepts will help resolve the problems we currently have in the clinical application of stem cell technology. The problem which we see today in stem cell technology, and the related regenerative medicine, is considerably magnified by the patient’s vulnerability, confusion, fear and blind trust in an atmosphere where the unwary can lose not only lots of money but also potentially their health.
The Regeneration Promise offers truly new and thorough insight into stem cell technology and it is written in a style that anyone can easily understand. There is no complex terminology (except where absolutely needed and if the terminology is used then it is carefully explained) and the stem cell concepts are described in a simple and accessible style that can be enjoyed and understood by all readers. The book is aimed at the general public, potential patients, physicians, students, journalists and anyone with a general interest in stem cell technology. No specialist knowledge is needed, and most importantly the information the book contains is evidence based and has no bias or hidden agenda. The Regeneration Promise is therefore a reliable and trusted point of reference for anyone either interested in stem cells or considering treatment using stem cells.
CONSENT FOR PUBLICATION
Not applicable.
CONFLICT OF INTEREST
The authors declare no conflict of interest, financial or otherwise.
ACKNOWLEDGEMENTS
Declared none.
DEDICATION
A Bit of History
Peter HollandsAbstract
A small body of determined spirits fired by an unquenchable faith in their mission can alter the course of history.Mahatma Gandhi
Abstract
Summary: This introductory chapter provides a general overview of the history of the development of the understanding of stem cell technology and the importance of stem cells to us all in everyday life. It provides important information on the basic science behind stem cell technology and it is an important foundation for readers to enjoy and understand the rest of the book.
Interesting Times
The year 1956 was interesting in many ways. Post-war recovery was progressing very well and new technology was being developed and brought into the home and the work place to make everyday lives easier and more productive. In the UK, luxuries such as the washing machine and vacuum cleaner were revolutionising the domestic role of women and optimism was high with the ending of rationing and a general post-war euphoria. In the Middle East, however, the ‘Suez Crisis’ brought great tension with Britain and France being drawn into military conflict in the area and Castro started a revolution in Cuba. Meanwhile, the first transatlantic telephone cable became operational while a young man called Elvis Presley was singing about his ‘Blue Suede Shoes’. It was, therefore, a year of some stress (not least dirty blue suede shoes), but at the same time, this was balanced by a ‘feel good’ factor perhaps enhanced by the newly discovered psychedelic drugs such as LSD and derivatives which would go on to dominate ‘flower power’ in the 1960’s. 1956 was also very important in the development of the understanding and clinical use of stem cells. Before we go any further with these ideas, it is necessary to properly understand what stem cells are and why they are important to us.
Stem Cells Are Everywhere!
Stem cells are present in every human being, mammal and some reptiles and no doubt will eventually be found in all species in some shape or form. Stem cell science is in its’ infancy and much more research is needed to come even close to an understanding of the importance and potential of stem cells. We can, however, be very certain that stem cells are essential for our normal development, normal health and possibly our ageing and eventual death. Stem cells may have been around since the first development of life on planet Earth (probably around 4.1 billion years ago) and no doubt exist in various types of life forms on other planets that are yet to be discovered (stem cells but not as we know it!).
Even in the early 21st century, we still have a lot to learn about stem cell biology and how we can manipulate stem cells to our benefit for our general health, treatment of disease and treatment of accidents such as spinal damage or burns. The unique properties of stem cells enable them to repair and regenerate tissue in our bodies for the whole of our lifespan which first develop in the early embryo at the very beginning of life. When stem cells go wrong then they can become the basis of very serious diseases such as leukaemia and cancer and understanding the nature of these ‘tumour forming’ stem cells will lead to a better understanding of how tumours arise and how they may be prevented or treated.
Bone Marrow Stem Cells
The most studied human stem cells to date are found in the bone marrow. Bone marrow is found inside the large bones of our skeleton, such as the thigh bone and the pelvis (hip bone). Bone marrow stem cells were the first stem cells to be discovered following many years of research on mouse bone marrow. These bone marrow stem cells in humans are capable of producing 200 billion red cells (these carry oxygen into the body and carbon dioxide out of the body), 10 billion white cells (these fight infection) and 400 billion platelets (these help to produce clots when needed) per day. The bone marrow stem cells are therefore known as ‘blood forming’ stem cells and without them blood, and therefore human life, would not exist in its present form. This astonishing feat by bone marrow stem cells means that just over 2000 red cells, just over 1000 white cells and just over 4000 platelets are produced every second in every one of us! This is biology at its’ most efficient and elegant state and we still have lots to learn about the process of forming blood, which is a remarkable process starting in the very early human embryo and carrying on until death.
The figures given above on blood cell production by bone marrow stem cells illustrate the importance of stem cells in our normal healthy lives and the enormous potential for problems when stem cells go wrong. The stem cells in the bone marrow are truly amazing but no less so than, for example, stem cells in skin which repair and rejuvenate our skin on a daily basis and stem cells in the whole of the gastrointestinal tract (mouth to anus) which repair and maintain the cells of this vital organ. Human life would be impossible without stem cells and when stem cells either stop working or become diseased then the consequences can be severe and sometimes even deadly.
Back Again to 1956
Getting back to 1956, the significant thing which happened this year in stem cell technology was the first human bone marrow stem cell transplant in the world. Dr E. Donnal ‘Don’ Thomas in the USA and his team were the pioneers and the patient was an identical twin who received bone marrow from her identical sibling. Identical twins have identical genetics, which means that tissue or cells can be transplanted from one twin to the other twin without any worry of rejection of the donated tissue or cells. The recipient patient twin would have been treated with chemotherapy (drugs which destroy cancer) and radiotherapy (X rays which destroy cancer) prior to the transplant. The donor twin would have undergone a bone marrow harvest under general anaesthetic to obtain the bone marrow stem cells for transplantation. Unlike a tissue transplant, such as a kidney transplant or heart transplant, bone marrow stem cells are transplanted to the recipient patient using the intravenous route (directly into a vein). This highlights an amazing feature of bone marrow stem cells: They can be injected into a vein and they find their way to the bone marrow where they ‘set-up home’ and begin making blood cells. This ‘homing’ of stem cells is a very useful property and is often utilised in stem cell transplants to other tissue where tissue specific stem cells can ‘home’ to the area of damage or disease and begin their repair process.
In 1990, Don Thomas and his colleague Joseph E. Murray were awarded the Nobel prize for their pioneering work in bone marrow stem cell transplantation. Better late than never!
Tissue Typing or ‘Tissue Matching’
These early bone marrow transplants were soon followed by a clear understanding in 1968 of the importance of ‘matching’ donor and recipient or this matching is also called tissue typing or Human Leucocyte Antigen (HLA) typing. Donors and recipients of bone marrow can be ‘matched’ to avoid or minimise ‘rejection’ or what is technically known as graft versus host disease (GvHD). This work was carried out by Dr. Jean Dausset and his colleagues Dr George Snell and Dr Baruj Benacerraf. These three scientists shared the Nobel prize for their work on tissue typing in transplantation in 1980. Once again better late than never!
The understanding of tissue typing meant that donor and recipient could be matched as far as possible, and therefore, the chances of rejection are considerably reduced. This made the whole process of bone marrow transplantation safer. This recognition of both Dr Don Thomas and Dr Jean Dausset and their colleagues by the Nobel committee illustrates the critical importance of their ground-breaking work, which is still the basis of many stem cell transplants today.
Nevertheless, rejection (or GvHD) can be fatal for some transplant patients so understanding and applying this knowledge was a very important step in the development of safe bone marrow stem cell transplantation to unrelated patients. This advance meant that bone marrow stem cells could be transplanted between unrelated people with relative safety assuming that a 99-100% match between donor and recipient can be found. This has resulted in over 1 million bone marrow stem cell transplants globally to date and these transplants often used bone marrow stem cells obtained from large international public stem cell banks such as Anthony Nolan in the UK or the New York Stem Cell Foundation.
This success in using bone marrow as a source of stem cells for transplantation marked the beginning of many years of stem cell research, extending to the present day, which in turn has made us aware of many different types of stem cells which exist in the body and their importance and potential. There will no doubt be many further discoveries in stem cell technology in the years to come, but the progress and innovation since 1956 and up to today have been beyond all expectations and let us hope that this momentum continues.
From Embryos to Stem Cells
The next important player in the stem cell story is Professor Sir Robert Edwards (known as Bob to his friends and colleagues) who worked at Cambridge University in the Physiological Laboratory (The Marshall Laboratory) and was a Fellow of Churchill College, Cambridge. Bob is much better known for his work in IVF (test-tube babies) as the pioneer of this technology, along with his physician colleague Mr Patrick Steptoe. Bob received the Nobel prize for his work on IVF in 2010. Unfortunately, Patrick Steptoe had died by the time the Nobel prize was awarded and therefore could not receive the award posthumously. Both Patrick and Bob can be seen in Fig. (1) which was at the first meeting of the European Society of Human Reproduction and Embryology (ESHRE) in Bonn in 1985. They were both dear friends, colleagues and mentors of mine and they are sadly missed by myself and hundreds of thousands of colleagues and patients around the World.
Getting back to stem cells, in the 1960’s to the Noughties Bob Edwards wrote some very important papers about stem cell technology with an amazing insight and understanding of what was happening at the time and what may happen in the future. His focus was on stem cell development in the early embryo and his ideas were the inspiration for me when I carried out research for my PhD at Cambridge University with Bob as my supervisor. Bob died in 2013 but his legacy in IVF and stem cell technology lives on today in every baby born by assisted reproduction and in concepts and developments in regenerative medicine.
Fig. (1)) Bob Edwards (on the right) and Patrick Steptoe (on the left) at the first meeting of the European Society of Human Reproduction and Embryology (ESHRE) in Bonn. I presented the stem cell work from my PhD at this meeting.From Mouse to Man?
It was the early 1980’s when a very handsome and intelligent young student, supervised by Bob Edwards, started research work to identify stem cells in the early mouse embryo (just after the mouse embryo has implanted into the uterus) and to attempt to use these cells to treat blood disease in other mice. Three years of research showed that there were indeed stem cells in the early mouse embryo and that these cells could be easily extracted and used to treat other mice suffering from blood disorders with great success. I created a very simple diagram of the basis of my work and made it into a 35mm slide, (Fig. 2). This slide travelled the World with Bob Edwards when he talked about my research at international conferences. It is perhaps one of the significant moments in regenerative medicine leading to some of the work and concepts we see today.
The research also confirmed the extraordinary properties of stem cells in the developing embryo which seemed to be capable of crossing transplant barriers such as tissue type and producing donor cells at an amazing rate. Cynics might say that this is good news if you happen to be a mouse and they are in part correct. Taking such ideas and technology from mouse to man is a massive and expensive technological and logistical task which I will cover later. Nevertheless, the results were still interesting to the overall understanding of the rapidly developing field of stem cell technology and earned me a PhD from Cambridge University! I thank the mice without whom this knowledge would have been impossible to obtain, they are all heroes.
Fig. (2)) A basic 35mm slide of my work, drawn by me, which Bob Edwards used in many international conferences.
